In conclusion, these findings demonstrate, for the first time, that miR-122 that is regulated by the upstream transcriptional factor HNF4α triggers MET to suppress HCC cell motility and invasion by targeting RhoA. This evidence concerns the gene MET and hepatocellular carcinoma.